ArticleMolecular biology reports2025
Upregulated expression of MYB4, DREB1 and AP37 transcription factors modulates cold stress response in high-altitude Himalayan rice via time-dependent ROS regulation.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Dynamic and non-additive gene regulation shapes maize responses to simultaneous salt and cold stress.Functional & integrative genomics · 2026Article
- Genetically Modified Plants in Agriculture.Biology · 2026Review
- Enhancement of chilling stress tolerance in ornamental chilli by exogenous application of salicylic acid and ascorbic acid revealed through transcriptomic profiling.Frontiers in plant science · 2026Article
- Article
- Phosphoproteomic Analysis Reveals Impairment of Rice Germination by Chloramphenicol.Plants (Basel, Switzerland) · 2025Article
- Genome-wide identification and characterization of DUF789 genes in cotton: implications for fibre development.BMC plant biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCold stress is an upcoming challenge for rice (Oryza sativa L.) cultivation, especially at the seedling establishment stage. It causes serious constraints in its production and productivity as it is a thermophilic cereal crop. North-western Himalayan region has a rich repository of temperate rice genotypes, and there is a need to identify cold-tolerant rice varieties from these available genetic resources. METHODS AND
resultsThe present study screened 90 rice accessions (indica and japonica) grown in the high-altitude regions at 2200 m amsl for cold tolerance (5 °C) at the seedling stage, and found 14 highly cold-tolerant accessions. Almost eighty per cent of the indica types clustered into cold-sensitive class. One cold-tolerant japonica (GS-74) accession and one cold-susceptible (SR-4) accession were used to compare their biochemical and gene expression response during cold stress and after recovery. A wide range of differences was noticed at different time points in the accumulation of ROS scavengers, osmo-protectants and antioxidant enzymes, with significant differences between the contrasting genotypes. Similarly, gene expression of five transcription factors OsMYB4, OsAP37, OsDREB1A, OsDREB1B and OsDREB1D revealed their role in cold responsiveness at the seedling stage, critically modulating the cold-induced osmoprotectant-mediated tolerance mechanism.
conclusionThis is the first study that explored the high-altitude Himalayan rice germplasm for cold tolerance at the critical S3 seedling stage under controlled conditions. It demonstrated that the upregulation of OsDREB1A, OsDREB1B, OsMYB4 and OsAP37 transcription factors modulates cold stress response in rice via a complex mechanism involving ROS scavengers and osmoprotectants.
Indexed as
Identifiers
40266391What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.